Edgewell Personal Care Company Sells Feminine Care for $340M, Tightens Portfolio

Edgewell Completes Feminine Care Sale, Tightens Portfolio

Edgewell Personal Care Company completes the divestiture of its Feminine Care business for $340 million, a move the Shelton, Connecticut-based personal care company says sharpens its portfolio and strengthens its balance sheet. Management presents the transaction as a stepping stone in the company’s multi-year transformation plan, saying the sale leaves Edgewell more focused and agile as it executes brand and operational initiatives across its remaining categories.

The company reports that reported results in the release are generally presented on a continuing operations basis that exclude Feminine Care as discontinued operations, while also providing some consolidated metrics to allow comparison with prior guidance issued on a consolidated basis. Edgewell estimates the annualized impact of the sale is favorable to its previous outlook and says the business is better positioned to concentrate investment and resources behind core brands and growth initiatives in shaving, sun care and other personal care segments.

CEO Rod Little says the company modestly exceeds expectations in organic net sales, adjusted earnings per share and adjusted EBITDA for the quarter, and stresses that a more streamlined business model supports efforts to drive sustainable growth and long-term value creation. The release, issued on Feb. 9, 2026, is accompanied by reconciliations of non‑GAAP measures to the most directly comparable GAAP figures.

Earnings snapshot and guidance

On a consolidated basis inclusive of the divested business, Edgewell reports net sales of $486.8 million for the quarter ended Dec. 31, 2025, up 1.8% year-on-year, while organic net sales — excluding currency movement — decline 0.3%. GAAP diluted net loss per share is $(1.41), compared with $(0.04) in the prior-year quarter; adjusted EPS are $0.03 versus $0.07 a year earlier. Management says adjusted EBITDA and adjusted EPS modestly outperform internal expectations for the quarter.

Following the transaction and related adjustments, Edgewell reiterates that its full-year outlook for continuing operations remains consistent with prior guidance for sales, adjusted EPS, adjusted EBITDA and free cash flow. Management notes that first-quarter guidance had been provided on a consolidated basis inclusive of Feminine Care, and presents continuing-operations metrics to reflect the company’s post-divestiture structure as it advances its transformation plan.